Arrowhead Pharmaceuticals (ARWR) Reports Q4 Loss of $1.34
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 60.05 +0.52 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.53 | 52 Week High | $8.22 | |||
| Open | $61.75 | 52 Week Low | $3.07 | |||
| Day High | $61.77 | P/E | N/A | |||
| Day Low | $60.04 | EPS | $-1.30 | |||
| Volume | 89,335 | |||||
